Inventor · disambiguated record
Douglas Grant Mcfadden
Also filed as: MCFADDEN DOUGLAS · MCFADDEN DOUGLAS G · MCFADDEN DOUGLAS GRANT
7 granted patents·8 pending applications·11 citations·filing 2012–2023
77Inventor score
Top patents by PatentIndex Score
15 records- 0190US11117934B2Oncolytic virus platform to treat cancers with myxoma virusUNIV ARIZONA STATE·Filed 2020·Granted Sep 14, 2021·6 cites·27 claims
- 0282US11685767B2Use of AAV-expressed M013 protein as an anti-inflammatory therapeuticUNIV FLORIDA·Filed 2016·Granted Jun 27, 2023·2 cites·27 claims
- 0374US12331079B2Oncolytic virus platform to treat cancers with myxoma virusUNIV ARIZONA STATE·Filed 2022·Granted Jun 17, 2025·0 cites·20 claims
- 0474US10322149B2Myxoma-treated graft material for cancer treatmentUNIV FLORIDA·Filed 2017·Granted Jun 18, 2019·1 cites·27 claims
- 0570US2024101607A1Use of aav-expressed m013 protein as an anti-inflammatory therapeuticUNIV FLORIDA·Filed 2023·Application pending·0 cites
- 0669US9730960B2Method for treating or preventing graft versus host diseaseMCFADDEN DOUGLAS G·Filed 2012·Granted Aug 15, 2017·2 cites·7 claims
- 0767US2018256656A1Use of a combination of myxoma virus and rapamycin for therapeutic treatmentUNIV WESTERN ONTARIO·Filed 2018·Application pending·0 cites
- 0864US2021324014A1A new oncolytic virus platform to treat cancers with myxoma virusUNIV ARIZONA STATE·Filed 2021·Application pending·0 cites
- 0962US2025249056A1Cancer therapies comprising a nuclear export inhibitor and an oncolytic virusUNIV ARIZONA STATE·Filed 2023·Application pending·0 cites
- 1055US12257278B2Methods of treating cancer with TNF expressing myxoma virusUNIV ARIZONA STATE·Filed 2019·Granted Mar 25, 2025·0 cites·15 claims
- 1150US2022088096A1Oncolytic myxoma virus expressing fast p14 to treat hematological cancerDUNCAN ROY·Filed 2021·Application pending·0 cites
- 1248US2022296660A1Methods and compositions for improving oncolytic virus infection for nonpermissive cancersUNIV ARIZONA STATE·Filed 2020·Application pending·0 cites
- 1346US2024093158A1Oncolytic viruses that express multi-specific immune cell engagersUNIV ARIZONA STATE·Filed 2020·Application pending·0 cites
- 1442US12398375B2Methods for improved poxvirus yieldsUNIV ARIZONA STATE·Filed 2019·Granted Aug 26, 2025·0 cites·12 claims
- 1542US2024091284A1Oncolytic virus comprising immunomodulatory transgenes and uses thereofUNIV ARIZONA STATE·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Douglas Grant Mcfadden files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →